Semaglutide impurity (des-8-Ser-SMT) is a structural analogue of Semaglutide and is an impurity that may be produced during its synthesis or degradation process. The impurity is missing the serine (Ser) at position 8, which may lead to changes in molecular structure and biological activity. Semaglutide is a long-acting GLP-1 receptor agonist widely used in the treatment of type 2 diabetes and obesity. Since impurities may affect the purity, stability and efficacy of the drug, the content of des-8-Ser-SMT must be strictly controlled during production and storage to ensure the safety and efficacy of the drug.
Product Overview
Basic Description |
Structure and function: |
Three-letter sequence |
His-Ala-Glu-Gly-Thr-Phe-Thr-Val-Asp-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly |
Single letter sequence |
HAEGETTFVDTYLGQAAKELIAWLVRGRG |
Molecular formula |
C178H259N45O54S |
Molecular weight |
4,051.9 g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C/-80°C away from light |